LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]

Wang Y, Wang X, Han L, Hu D. Cancer Manag Res. 2020;12:9999–10010. At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors raised concerns over similarities between the flow cytometry data provided in Figures 2,...

Full description

Bibliographic Details
Main Authors: Wang Y, Wang X, Han L, Hu D
Format: Article
Language:English
Published: Dove Medical Press 2022-12-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/retraction-lncrna-malat1-regulates-the-progression-and-cisplatin-resis-peer-reviewed-fulltext-article-CMAR
_version_ 1811197458906087424
author Wang Y
Wang X
Han L
Hu D
author_facet Wang Y
Wang X
Han L
Hu D
author_sort Wang Y
collection DOAJ
description Wang Y, Wang X, Han L, Hu D. Cancer Manag Res. 2020;12:9999–10010. At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors raised concerns over similarities between the flow cytometry data provided in Figures 2, 4 and 7 and indicated that it may have been fabricated. In addition, the authors advised that the cell migration and invasion data also provided in Figures 2, 4 and 7 was unreliable. The authors were unable to provide original data for their study and could not verify the reported findings. The Editor agreed with the authors decision to retract the article. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
first_indexed 2024-04-12T01:15:10Z
format Article
id doaj.art-2551a03d65f04bf3a288467ac1cb06a6
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-04-12T01:15:10Z
publishDate 2022-12-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-2551a03d65f04bf3a288467ac1cb06a62022-12-22T03:54:00ZengDove Medical PressCancer Management and Research1179-13222022-12-01Volume 143457345880359LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]Wang YWang XHan LHu DWang Y, Wang X, Han L, Hu D. Cancer Manag Res. 2020;12:9999–10010. At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors raised concerns over similarities between the flow cytometry data provided in Figures 2, 4 and 7 and indicated that it may have been fabricated. In addition, the authors advised that the cell migration and invasion data also provided in Figures 2, 4 and 7 was unreliable. The authors were unable to provide original data for their study and could not verify the reported findings. The Editor agreed with the authors decision to retract the article. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.https://www.dovepress.com/retraction-lncrna-malat1-regulates-the-progression-and-cisplatin-resis-peer-reviewed-fulltext-article-CMARovarian cancermalat1mir-1271-5pe2f5cisplatin
spellingShingle Wang Y
Wang X
Han L
Hu D
LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]
Cancer Management and Research
ovarian cancer
malat1
mir-1271-5p
e2f5
cisplatin
title LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]
title_full LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]
title_fullStr LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]
title_full_unstemmed LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]
title_short LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction]
title_sort lncrna malat1 regulates the progression and cisplatin resistance of ovarian cancer cells via modulating mir 1271 5p e2f5 axis retraction
topic ovarian cancer
malat1
mir-1271-5p
e2f5
cisplatin
url https://www.dovepress.com/retraction-lncrna-malat1-regulates-the-progression-and-cisplatin-resis-peer-reviewed-fulltext-article-CMAR
work_keys_str_mv AT wangy lncrnamalat1regulatestheprogressionandcisplatinresistanceofovariancancercellsviamodulatingmir12715pe2f5axisretraction
AT wangx lncrnamalat1regulatestheprogressionandcisplatinresistanceofovariancancercellsviamodulatingmir12715pe2f5axisretraction
AT hanl lncrnamalat1regulatestheprogressionandcisplatinresistanceofovariancancercellsviamodulatingmir12715pe2f5axisretraction
AT hud lncrnamalat1regulatestheprogressionandcisplatinresistanceofovariancancercellsviamodulatingmir12715pe2f5axisretraction